Mini-hyper-CVD with low-dose inotuzumab ozogamicin is an effective induction strategy for adults with immunomodulatory drug-associated B-cell acute lymphoblastic leukemia.

Authors

Leora Boussi, Ettaib El Marabti, Brian Shaffer, Heather Landau, Yanming Zhang, Wenbin Xiao, Mikhail Roshal, Aaron D Goldberg, Eytan M Stein, Jae H Park, Mark B Geyer

Published in

Leukemia research. Volume 171. Pages 108331. Sep 29, 2026. Epub Sep 29, 2026.

PMID:
42828839
Bibliographic data and abstract were imported from PubMed on 04 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.